Numeric Investors’s Ligand Pharmaceuticals LGND Stock Holding History

Numeric Investors’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$18.5M	Buy	216,405 +62,838	+41%	+$5.45M	0.13%	155
2017 Q3	$13M	Buy	153,567 +110,607	+257%	+$8.76M	0.1%	185
2017 Q2	$3.25M	Buy	+42,960	New	+$3.01M	0.03%	410
2016 Q2	–	Sell	-25,488	Closed	-$1.7M	–	1101
2016 Q1	$1.7M	Sell	25,488 -962	-4%	-$58.5K	0.02%	458
2015 Q4	$1.79M	Buy	26,450 +21,481	+432%	+$1.33M	0.02%	461
2015 Q3	$266K	Buy	+4,969	New	+$301K	﹤0.01%	871
2014 Q2	–	Sell	-19,396	Closed	-$814K	–	851
2014 Q1	$814K	Buy	+19,396	New	+$808K	0.01%	476

Other funds holding LGND

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

DMK

David M. Knott $275M AUM 59.23% 1-Year Est. Return

CCMLC

Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Numeric Investors's LGND Position: Q4 2017 in Review

Numeric Investors increased its Ligand Pharmaceuticals (LGND) stake by 41% in Q4 2017, buying an estimated $5.45M and bringing the position to 216,405 shares worth $18.5M. The position accounts for 0.13% of the portfolio, ranked #155.

Numeric Investors first reported a position in LGND in Q1 2014 and has held it in 7 quarters since. 298 funds tracked by Wall St. Rank hold LGND as of Q4 2017.

Numeric Investors held 216,405 shares of Ligand Pharmaceuticals worth $18.5M as of Q4 2017.
Numeric Investors bought 62,838 Ligand Pharmaceuticals shares in Q4 2017, an estimated $5.45M.
Ligand Pharmaceuticals made up 0.13% of Numeric Investors's portfolio in Q4 2017, its #155 holding.
Numeric Investors first reported a position in Ligand Pharmaceuticals in Q1 2014 and has held it in 7 quarters since.
298 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q4 2017.

Based on Numeric Investors's 13F filing for Q4 2017, filed 14 Feb 2018.